These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 22534488)
1. Positive predictive value of the International Classification of Diseases, 10th revision, codes to identify osteonecrosis of the jaw in patients with cancer. Gammelager H; Erichsen R; Antonsen S; Nørholt SE; Neumann-Jensen B; Ehrenstein V; Acquavella J; Sørensen HT Cancer Epidemiol; 2012 Aug; 36(4):381-3. PubMed ID: 22534488 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients. Ehrenstein V; Gammelager H; Schiødt M; Nørholt SE; Neumann-Jensen B; Folkmar TB; Pedersen L; Svaerke C; Sørensen HT; Ma H; Acquavella J Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):693-700. PubMed ID: 25974710 [TBL] [Abstract][Full Text] [Related]
3. Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients. Gammelager H; Sværke C; Noerholt SE; Neumann-Jensen B; Xue F; Critchlow C; Bergdahl J; Lagerros YT; Kieler H; Tell GS; Ehrenstein V Clin Epidemiol; 2013; 5():263-7. PubMed ID: 23946670 [TBL] [Abstract][Full Text] [Related]
4. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP; Kaban LB; Strewler GJ; Raje N; Troulis MJ J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483 [TBL] [Abstract][Full Text] [Related]
6. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Mavrokokki T; Cheng A; Stein B; Goss A J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586 [TBL] [Abstract][Full Text] [Related]
7. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the jaw: who gets it, and why? Reid IR Bone; 2009 Jan; 44(1):4-10. PubMed ID: 18948230 [TBL] [Abstract][Full Text] [Related]
9. Positive predictive value of primary inpatient discharge diagnoses of infection among cancer patients in the Danish National Registry of Patients. Holland-Bill L; Xu H; Sørensen HT; Acquavella J; Sværke C; Gammelager H; Ehrenstein V Ann Epidemiol; 2014 Aug; 24(8):593-7, 597.e1-18. PubMed ID: 25084702 [TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738 [TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonates and osteonecrosis of the jaws]. Urade M Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882 [TBL] [Abstract][Full Text] [Related]
13. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. Helqvist L; Erichsen R; Gammelager H; Johansen MB; Sørensen HT Eur J Cancer Care (Engl); 2012 Nov; 21(6):722-7. PubMed ID: 22510213 [TBL] [Abstract][Full Text] [Related]
14. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913 [TBL] [Abstract][Full Text] [Related]
15. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ripamonti CI; Maniezzo M; Campa T; Fagnoni E; Brunelli C; Saibene G; Bareggi C; Ascani L; Cislaghi E Ann Oncol; 2009 Jan; 20(1):137-45. PubMed ID: 18647964 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Hoff AO; Toth B; Hu M; Hortobagyi GN; Gagel RF Ann N Y Acad Sci; 2011 Feb; 1218():47-54. PubMed ID: 20946574 [TBL] [Abstract][Full Text] [Related]
17. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study. Lee CY; Suzuki JB Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814 [TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw: an update and review of recommendations. Novince CM; Ward BB; McCauley LK Cells Tissues Organs; 2009; 189(1-4):275-83. PubMed ID: 18765930 [TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. King AE; Umland EM Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663 [TBL] [Abstract][Full Text] [Related]
20. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review]. Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]